Hexamer Therapeutics, Inc
Rapidly engineered, scalable vaccine platform technology
- Sector
- Biotech
- Headquarters
- PULLMAN, WA
- Founded
- 2019
- Latest Form D
- $500K, Sep 2026
- Total capital
- $1.6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.6M
- 3 Form D · last Sep 2026
- 1 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 6 pending · first 2025
- Rank in peer group#46 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$500K
- Private capital raisedForm D · SEC · 2nd filing$651K
- Private capital raisedForm D · SEC · 1st filing$470K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#46 · top 13%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Colin Conrad CollinsExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Keith David MillerExecutive Officer, Director, PromoterNamed in SEC Form D filings
- ROBERT H BOGDENExecutive Officer, Director, PromoterNamed in SEC Form D filings
- R. SCOTT H BLACKLEYDirectorNamed in SEC Form D filings
- STEPHEN H CRAWFORDDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 9- GrantedVaccines Against Viral PathogensUSPTOUS 12,673,096
- GrantedAn Immunotherapeutic For Prostate Cancer TreatmentUSPTOUS 12,648,985
- PendingSelf-assembling Peptide ScaffoldUSPTOApplication 19370520
Show all 9 patent records
- Vaccines Against Viral PathogensJul 7, 2026 · US 12,673,096Granted
- An Immunotherapeutic For Prostate Cancer TreatmentJun 9, 2026 · US 12,648,985Granted
- Self-assembling Peptide ScaffoldMar 5, 2026 · Application 19370520Pending
- Self-assembling Peptide ScaffoldNov 4, 2025 · US 12,458,692Granted
- Vaccines Against Viral PathogensApplication PCTUS2021030579Pending
- An Immunotherapeutic For Prostate Cancer TreatmentApplication PCTUS2020050194Pending
- Vaccines Against Viral PathogensApplication 63019654Pending
- Vaccine For Prostate Cancer TreatmentApplication 62899553Pending
- Self-assembling Peptide ScaffoldApplication PCTUS2019041601Pending
Related companies, and why
- Alixia, Inc.Similar federal contract value in Biotech · null in contracts
- AP NeomorphSimilar federal contract value in Biotech · null in contracts
- NuvOx Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- SANO CHEMICALS, INCSimilar federal contract value in Biotech · null in contracts
- Truvitech, LLCSimilar federal contract value in Biotech · null in contracts
- Telomir Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .